Ryan Mathew is an Associate Professor at the University of Leeds (UoL) and Honorary Consultant Neurosurgeon at the Leeds Teaching Hospitals NHS Trust (http://www.leedsneurosurgery.com). He obtained an MBChB with Honours and an intercalated BSc with Honours, the latter in Clinical Sciences (Tissue Engineering) research. During his neurosurgical training/residency, he undertook further basic science research (funded by Cancer Research UK) into brain cancer and was awarded a PhD based on Glioma Modelling using induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids. He subsequently spent time as a Visiting Research Collaborator at the Brain Tumour Research Centre at Sickkids in Toronto.

His research interests include basic and translational research into brain cancer, preclinical model development, medical devices, surgical technologies and immersive. At the University of Leeds, he co-leads the Stem Cells and Brain Tumour Group with Dr Heiko Wurdak (http://www.braincancer.leeds.ac.uk/stem-cells-and-brain-tumour-research-group/), he is Academic Lead for Health and Wellbeing at the Centre for Immersive Technologies (https://www.leeds.ac.uk/info/130571/centre_for_immersive_technologies), Neurosurgical Lead for the National Institute of Health Research (NIHR) Surgical MedTechCooperative (https://surgicalmic.nihr.ac.uk/about-us/meet-the-team/), Neurosurgical Lead and Steering Committee Member of the Leeds Institute of Clinical Trials Research and was recently part of the successful bid to become an NIHR Academy Advanced Surgical Technology Incubator (a joint initiative between Leeds and UCL). He is passionate about research public engagement and was awarded a Flame of Hope for Research Engagement by Cancer Research UK.

He has a clinical subspecialist interest in all types of brain tumours, with a special focus on glioma, meningiomas and awake surgery. He is Co-Lead for Medical Research Council (MRC) Brain Tissue Liaison for the Society of British Neurological Surgeons (SBNS) Academic Committee https://www.sbns.org.uk/index.php/research/academic-neurosurgeons/), and a member of the National Cancer Research Institute’s Glioma Subgroup.